Sanofi and GSK say they're near a vac­cine deal with EU hours af­ter fi­nal­iz­ing Warp Speed con­tract

On the heels of land­ing the largest Warp Speed con­tract to date, Sanofi and Glax­o­SmithK­line con­tin­ued to make moves Fri­day af­ter­noon.

The two com­pa­nies an­nounced they are in ad­vanced dis­cus­sions with the EU to sup­ply up to 300 mil­lion dos­es of their Covid-19 vac­cine can­di­date, com­ing just a few hours af­ter se­cur­ing their $2.1 bil­lion deal with the US. Should the agree­ment be fi­nal­ized, all EU mem­ber states will have the op­tion to pur­chase the vac­cine.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER